Table 1. Significant differences in the gene expression profile of the corresponding tumor tissues between the CGGP-defined subgroups.
| Cancer type |
CGGP-defined subgroups |
Function term | P | FDR |
| Bladder | 2 versus 3 | Pathways and metabolism | 9.80 × 10−13 | 1.81 × 10−9 |
| Bladder | 2 versus 3 | Ubiquitin and protein degradation |
6.20 × 10−6 | 0.01 |
| Bladder | 1 versus 3 | Pathways and metabolism | 8.31 × 10−9 | 1.54 × 10−5 |
| Brain | 1 versus2 | Ubiquitin and protein degradation |
7.87 × 10−6 | 0.01 |
| Brain | 1 versus2 | Pathways and metabolism | 1.13 × 10−5 | 0.02 |
| Cervical | 1 versus 3 | Pathways and metabolism | 9.80 × 10−13 | 1.81 × 10−9 |
| Cervical | 1 versus 3 | Ubiquitin and protein degradation |
9.03 × 10−6 | 0.02 |
| Cervical | 2 versus 3 | Pathways and metabolism | 8.31 × 10−9 | 1.54 × 10−5 |
| Kidney | 3 versus 1 | Pathways and metabolism | 9.80 × 10−13 | 1.81 × 10−9 |
| Kidney | 3 versus 1 | Ubiquitin and protein degradation |
6.20 × 10−6 | 0.01 |
| Lung | 2 versus 1 | Pathways and metabolism | 8.12 × 10−17 | 2.00 × 10−13 |
| Lung | 2 versus 1 | Ubiquitin and protein degradation |
7.18 × 10−12 | 1.29 × 10−8 |
| Lung | 2 versus 1 | Mitochondria | 1.69 × 10−8 | 3.04 × 10−5 |
| Lung | 2 versus 1 | Cell cycle | 4.70 × 10−8 | 8.42 × 10−5 |
| Lung | 3 versus 1 | Ubiquitin and protein degradation |
2.14 × 10−7 | 3.97 × 10−4 |
| Uterine | 3 versus 1 | Pathways and metabolism | 9.80 × 10−13 | 1.81 × 10−13 |
| Uterine | 3 versus 1 | Ubiquitin and protein degradation |
2.04 × 10−5 | 0.04 |
| Uterine | 2 versus 1 | Pathways and metabolism | 8.31 × 10−9 | 1.54 × 10−5 |